“…In the meanwhile, it would be extremely important for people who are now living the dramatic condition of HD prospective trials be undertaken to assess the clinical utility of fetal-tissue based therapies. Certainly, several challenges remain to be faced, including overall optimization of graft procedure and patient management (Baizabal-Carvallo, 2014 ; Bachoud-Lévi and Perrier, 2014 ). However, based on what we have learned up to now, it seems appropriate not to neglect this approach and keep going.…”